U, R., A, A., S, S., R, K., H, H., CA, P. M., . . . M, F. (2025). Long-Term Outcomes of Rituximab Therapy in Autoimmune Hemolytic Anemia: A Systematic Review and Meta-Analysis. Cureus, 17(5), e83962. https://doi.org/10.7759/cureus.83962
Chicago Style (17th ed.) CitationU, Rizwanullah, et al. "Long-Term Outcomes of Rituximab Therapy in Autoimmune Hemolytic Anemia: A Systematic Review and Meta-Analysis." Cureus 17, no. 5 (2025): e83962. https://doi.org/10.7759/cureus.83962.
MLA (9th ed.) CitationU, Rizwanullah, et al. "Long-Term Outcomes of Rituximab Therapy in Autoimmune Hemolytic Anemia: A Systematic Review and Meta-Analysis." Cureus, vol. 17, no. 5, 2025, p. e83962, https://doi.org/10.7759/cureus.83962.
Warning: These citations may not always be 100% accurate.